These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 38162075)

  • 1. [Retrospective Analysis of the Effect of Uric Acid on the Prognosis of Immunoglobulin A Nephropathy With Stage 3-4 Chronic Kidney Disease].
    Yu Z; Qin Y; Yuan J; Zhao J; Sun S
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 Nov; 54(6):1121-1127. PubMed ID: 38162075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathological Characteristics and Outcomes of Immunoglobulin A Nephropathy with Different Types of Dyslipidemia: A Retrospective Single-Center Study.
    Liu S; Lu Z; Fu Z; Li H; Gui C; Deng Y
    Kidney Blood Press Res; 2023; 48(1):186-193. PubMed ID: 37062274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uric Acid as a Predictor of Immunoglobulin A Nephropathy Progression: A Cohort Study of 1965 Cases.
    Zhu B; Yu DR; Lv JC; Lin Y; Li Q; Yin JZ; Du YY; Tang XL; Mao LC; Li QF; Sun Y; Liu L; Li XF; Fei D; Wei XY; Zhu CF; Cheng XX; Chen HY; Wang YJ
    Am J Nephrol; 2018; 48(2):127-136. PubMed ID: 30110674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High uric acid level is a risk factor for progression of IgA nephropathy with chronic kidney disease stage G3a.
    Moriyama T; Itabashi M; Takei T; Kataoka H; Sato M; Shimizu A; Iwabuchi Y; Nishida M; Uchida K; Nitta K
    J Nephrol; 2015 Aug; 28(4):451-6. PubMed ID: 25355499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between blood neutrophil-lymphocyte ratio and renal tubular atrophy/interstitial fibrosis in IgA nephropathy patients.
    Chai L; Cai K; Wang K; Luo Q
    J Clin Lab Anal; 2021 Jun; 35(6):e23774. PubMed ID: 33951240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperuricemia and hypertriglyceridemia indicate tubular atrophy/interstitial fibrosis in patients with IgA nephropathy and membranous nephropathy.
    Liu B; Zhao L; Yang Q; Zha D; Si X
    Int Urol Nephrol; 2021 Nov; 53(11):2321-2332. PubMed ID: 33895976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperuricemia and its related histopathological features on renal biopsy.
    Fan S; Zhang P; Wang AY; Wang X; Wang L; Li G; Hong D
    BMC Nephrol; 2019 Mar; 20(1):95. PubMed ID: 30885171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased serum uric acid levels are associated to renal arteriolopathy and predict poor outcome in IgA nephropathy.
    Russo E; Drovandi S; Salvidio G; Verzola D; Esposito P; Garibotto G; Viazzi F
    Nutr Metab Cardiovasc Dis; 2020 Nov; 30(12):2343-2350. PubMed ID: 32912790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and prognostic significance of C1q deposition in IgAN patients-a retrospective study.
    Tian S; Yang X; Luo J; Guo H
    Int Immunopharmacol; 2020 Nov; 88():106896. PubMed ID: 33182045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperuricemia has increased the risk of progression of chronic kidney disease: propensity score matching analysis from the KNOW-CKD study.
    Oh TR; Choi HS; Kim CS; Bae EH; Ma SK; Sung SA; Kim YS; Oh KH; Ahn C; Kim SW
    Sci Rep; 2019 Apr; 9(1):6681. PubMed ID: 31040373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Related Factors of Hyperuricemia in IgA Nephropathy.
    Yi F; Lan L; Jiang J; Peng L; Jin Y; Zhou X
    Iran J Kidney Dis; 2021 Jul; 15(4):256-262. PubMed ID: 34278996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum uric acid level is correlated with the clinical, pathological progression and prognosis of IgA nephropathy: an observational retrospective pilot-study.
    Lu P; Li X; Zhu N; Deng Y; Cai Y; Zhang T; Liu L; Lin X; Guo Y; Han M
    PeerJ; 2020; 8():e10130. PubMed ID: 33194389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of time-averaged serum uric acid level with clinicopathological information and long-term outcomes in patients with IgA nephropathy.
    Weng M; Fu B; Zhuo Y; Lin J; Zou Z; Chen Y; Cui J; Li G; Chen C; Xu Y; Jiang D; Wan J
    PeerJ; 2024; 12():e17266. PubMed ID: 38650643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and pathological features of immunoglobulin A nephropathy patients with nephrotic syndrome.
    Han X; Xiao Y; Tang Y; Zheng X; Anwar M; Qin W
    Clin Exp Med; 2019 Nov; 19(4):479-486. PubMed ID: 31542837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum Uric Acid Level Predicts Progression of IgA Nephropathy in Females but Not in Males.
    Nagasawa Y; Yamamoto R; Shoji T; Shinzawa M; Hasuike Y; Nagatoya K; Yamauchi A; Hayashi T; Kuragano T; Moriyama T; Isaka Y; Nakanishi T
    PLoS One; 2016; 11(8):e0160828. PubMed ID: 27560997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathological Characteristics, Role of Immunosuppressive Therapy and Progression in IgA Nephropathy with Hyperuricemia.
    Ruan Y; Hong F; Wu J; Lin M; Wang C; Lian F; Cao F; Yang G; Gao M
    Kidney Blood Press Res; 2018; 43(4):1131-1140. PubMed ID: 30016775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prognostic value of the systemic immune inflammation index in patients with IgA nephropathy.
    Zhai Y; Sun S; Zhang W; Tian H
    Ren Fail; 2024 Dec; 46(2):2381613. PubMed ID: 39039867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Effects of Hyperuricemia on the Prognosis of IgA Nephropathy are More Potent in Females.
    Oh TR; Choi HS; Kim CS; Kang KP; Kwon YJ; Kim SG; Ma SK; Kim SW; Bae EH
    J Clin Med; 2020 Jan; 9(1):. PubMed ID: 31936416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and prognostic implications of serum uric acid levels on IgA nephropathy: a cohort study of 348 cases with a mean 5-year follow-up.
    Cheng GY; Liu DW; Zhang N; Tang L; Zhao ZZ; Liu ZS
    Clin Nephrol; 2013 Jul; 80(1):40-6. PubMed ID: 23391320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperuricemia is associated with progression of IgA nephropathy.
    Bakan A; Oral A; Elcioglu OC; Takir M; Kostek O; Ozkok A; Basci S; Sumnu A; Ozturk S; Sipahioglu M; Turkmen A; Voroneanu L; Covic A; Kanbay M
    Int Urol Nephrol; 2015 Apr; 47(4):673-8. PubMed ID: 25761742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.